Shuttle Pharmaceuticals Rings the Opening Bell

About This Event

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy (RT) while reducing side effects, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Anatoly Dritschilo, M.D., CEO, rings the Opening Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore